FNDC5 and atherosclerosis: Furthermore, the supplementation of exogenous irisin has been shown to ameliorate AGE (advanced glycation end product)-induced inflammation and endothelial dysfunction by inhibiting ROS-NLRP3 (NOD-like receptor family pyrin domain containing 3) inflammasome signaling, and changes the progression of atherosclerosis [75].